Age-related histological changes in the canine substantia nigra

Journal of Veterinary Medical Science

Volumn 65, Issue 2, 2003, Pages 179-185

  Uchida, Kazuyuki ^a   Kihara, Nana ^a   Hashimoto, Kana ^a   Nakayama, Hiroyuki ^b   Yamaguchi, Ryoji ^a   Tateyama, Susumu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aging; Canine; Inclusion body; Senile change; Substantia nigra

Indexed keywords

CANIS FAMILIARIS;

GLIAL FIBRILLARY ACIDIC PROTEIN; SINGLE STRANDED DNA; TYROSINE 3 MONOOXYGENASE; UBIQUITIN;

AGING; ANIMAL; APOPTOSIS; ARTICLE; CHEMISTRY; CYTOLOGY; DOG; DOG DISEASE; FEMALE; HISTOLOGY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SUBSTANTIA NIGRA;

AGING; ANIMALS; APOPTOSIS; DNA, SINGLE-STRANDED; DOG DISEASES; DOGS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; UBIQUITIN;

EID: 0043269329     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.65.179     Document Type: Article

References (34)

1. Baba, M., Nakajo, S., Tu, P. H., Tomita, T., Nakaya, K., Lee. V. M., Trojanowski, J.Q. and Iwatsubo, T. 1998. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152: 879-884.
2. Bancher, C., Lassmann, H., Budka, H., Jellinger, K., Grundke-Iqbal, I., Iqbal, K., Wiche, G., Seitelberger. F. and Wisniewski, H. M. 1989. An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J. Neuropathol. Exp. Neurol. 48: 81-93.
3. Beal, M. F. 1992. Does impairment of energy metabolism result in toxic neuronal death in neurodegenerative illness? Ann. Neurol. 31: 119-130.
4. Bignami, A., Eng, L. F., Dahl, D. and Uyeda, C.T. 1972. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res. 43: 429-435.
5. Borras, D., Ferrer, I. and Pumarola, M. 1999. Age-related changes in the brain of the dog. Vet. Pathol. 36: 202-211.
6. Cummings, B. J., Head, E., Ruehl, W., Milgram, N. W. and Cotman, C. W. 1996. The canine as an animal model of human aging and dementia. Neurobiol. Aging. 17: 259-268.
7. Favit, A., Grimaldi, M. and Alkon, D. L. 2000. Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway. J. Neurochem. 75: 1258-1263.
8. Fearnley, J. M. and Lees, A. J. 1991. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301.
9. Gai, W. P., Blessing, W. W. and Blumbergs, P. C. 1995. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 118: 1447-1459.
10. Gaspar, P., Berger, B., Febvret, A., Vigny, A., Krieger-Poulet, M. and Borri-Voltattorni, C. 1987. Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: a novel catecholaminergic group? Neurosci. Lett. 80: 257-262.
11. Gomez-Tortosa, E., Newell, K., Irizarry, M. C., Sanders, J. L. and Hyman, B. T. 2000. Alpha-synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol. (Berl.) 99: 352-357.
12. Hornung, J. P., Tork, I. and de-Tribolet, N. 1989. Morphology of tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex. Exp. Brain. Res. 76: 12-20.
13. Irwin, I., DeLanney, L. E., McNeill, T., Chan, P., Forno, L. S., Murphy, G. M. Jr., Di Monte, D. A., Sandy, M. S. and Langston, J. W. 1994. Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration 3: 251-265.
14. Iwatsubo, T. 1999. Familial Parkinson's disease: Lewy bodies and alpha-synuclein. Cell Technol 18: 809-813.
15. Kiatipattanasakul, W., Nakamura, S., Hossain, M. M., Nakayama, H., Uchino, T., Shumiya, S., Goto, N. and Doi, K. 1996. Apoptosis in the aged dog brain. Acta Neuropathol. (Berl.) 92: 242-248.
16. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 1998. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (Lond.) 392: 605-608.
17. Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M. and Ihara, Y. 1988. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. (Berl.) 75: 345-353.
18. Lowe, J., Mayer, R. J. and Landon, M. 1993. Ubiquitin in neurodegenerative diseases. Brain Pathol. 3: 55-65.
19. Lucking, C. B. and Brice, A. 2000. Alpha-synuclein and Parkinson's disease. Cell Mol. Life Sci. 57: 1894-1908.
20. Magnusson, K. R., Scanga, C., Wagner, A. E. and Dunlop, C. 2000. Changes in anesthetic sensitivity and glutamate receptors in the aging canine brain. J. Gerontol. A. Biol. Sci. Med. Sci. 55: B448-454.
21. Mattson, M. P., Duan, W., Pedersen, W. A. and Culmsee, C. 2001. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6: 69-81.
22. Migheli, A., Attanasio, A., Pezzulo, T., Gullotta, F., Giordana, M. T. and Schiffer, D. 1992. Age-related ubiquitin deposits in dystrophic neurites: an immunoelectron microscopic study. Neuropathol. Appl. Neurobiol. 18: 3-11.
23. Nakamura, S., Tamaoka, A., Sawamura, N., Kiatipattanasakul, W., Nakayama, H., Shoji, S., Yoshikawa, Y. and Doi, K. 1997. Deposition of amyloid beta protein (A beta) subtypes [A beta 40 and A beta 42(43)] in canine senile plaques and cerebral amyloid angiopathy. Acta Neuropathol. (Berl.) 94: 323-328.
24. Perry, R. H., Irving, D. and Tomlinson, B. E. 1990. Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J. Neurol. Sci. 100: 223-233.
25. Polymeropoulos, M. H., Lavedan, C., Leroy E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di-Iorio, G., Golbe, L. I. and Nussbaum, R. L. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
26. Ross, M. E., Reis, D. J. and Joh, T. H. 1981. Monoclonal antibodies to tyrosine hydroxylase: production and characterization. Brain Res. 208: 493-498.
27. Siddiqi, Z., Kemper, T. L. and Killiany, R. 1999. Age-related neuronal loss from the substantia nigra-pars compacta and ventral tegmental area of the rhesus monkey. J. Neuropathol. Exp. Neurol. 58: 959-971.
28. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. and Goedert, M. 1998. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95: 6469-6473.
29. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. and Goedert, M. 1997. Alpha-synuclein in Lewy bodies. Nature (Lond.) 388: 839-840.
30. Suzuki, Y., Atoji, Y. and Suu, S. 1978. Microtubules observed within the cistern of RER in neurons of the aged dog. Acta Neuropathol. (Berl.) 44: 155-158.
31. Uchida, K., Nakayama, H. and Goto, N. 1991. Pathological studies on cerebral amyloid angiopathy, senile plaques and amyloid deposition in visceral organs in aged dogs. J. Vet. Med. Sci. 53: 1037-1042.
32. Ueda, S., Aikawa, M., Ishizuya-Oka, A., Yamaoka, S., Koibuchi, N. and Yoshimoto, K. 2000. Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: regional fiber vulnerability in the striatum and the olfactory tubercle. Neuroscience 95: 389-398.
33. Vincent, S. R. 1988. Distributions of tyrosine hydroxylase-, dopamine-beta- hydroxylase-, and phenylethanolamine-N-methyltransferase immuno- reactive neurons in the brain of the hamster (Mesocricetus auratus). J. Comp. Neurol. 268: 584-599.
34. van Duinen, S. G., Lammers, G. J., Maat-Schieman, M. L. and Roos, R. A. 1999. Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient. Acta Neuropathol. (Berl.) 97: 533-539.